Form 4: Twist Bioscience COO Sells Shares for Tax Obligations

Twist Bioscience's President and COO, Patrick John Finn, sold 1,840 shares of common stock to cover tax withholding obligations related to vested Restricted Stock Units.

Summary

• Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), reported a sale of company common stock.
• The transaction involved 1,840 shares of common stock.
• The shares were sold at a price of $25.964 per share on August 21, 2025.
• The sale was non-discretionary, executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• This "sell to cover" transaction was mandated by the Issuer's equity incentive plans.
• Following the transaction, Finn beneficially owns 233,529 shares of Twist Bioscience common stock directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: A 'sell to cover' transaction is a neutral event. It is a routine administrative action for tax purposes upon RSU vesting and does not reflect a discretionary decision by the insider regarding the company's future prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a non-discretionary tax-related sale, not indicative of a change in management's confidence.
• Employees: No direct impact on employees beyond the reporting person.

Key Dates

Keywords

Twist Bioscience, TWST, Form 4, Insider Trading, Patrick John Finn, Stock Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Corporate Officer